Lvwen Zhang, Zhenyu Song, Xike Mao, Yuehan Yang, Bingbing Hou, Yang Chen et al. Corrigendum to “The SIRT6 allosteric activator MDL-800 suppresses calcium oxalate nephrocalcinosis by alleviating inflammatory and renal damage” [Int. Immunopharmacol. 146 (2025) 113864]. // International Immunopharmacology. – DOI: 10.1016/j.intimp.2026.117587. – URL: https://www.sciencedirect.com/science/article/pii/S1567576926014359?dgcid=rss_sd_all
Lvwen Zhang, Zhenyu Song, Xike Mao, Yuehan Yang, Bingbing Hou, Yang Chen, & Zongyao Hao Corrigendum to “The SIRT6 allosteric activator MDL-800 suppresses calcium oxalate nephrocalcinosis by alleviating inflammatory and renal damage” [Int. Immunopharmacol. 146 (2025) 113864]. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117587
Lvwen Zhang, et al. “Corrigendum to “The SIRT6 allosteric activator MDL-800 suppresses calcium oxalate nephrocalcinosis by alleviating inflammatory and renal damage” [Int. Immunopharmacol. 146 (2025) 113864].” International Immunopharmacology. doi:10.1016/j.intimp.2026.117587.
@article{Zhang,
title = {Corrigendum to “The SIRT6 allosteric activator MDL-800 suppresses calcium oxalate nephrocalcinosis by alleviating inflammatory and renal damage” [Int. Immunopharmacol. 146 (2025) 113864]},
author = {Zhang, Lvwen and Song, Zhenyu and Mao, Xike and Yang, Yuehan and Hou, Bingbing and Chen, Yang and Hao, Zongyao},
journal = {International Immunopharmacology},
doi = {10.1016/j.intimp.2026.117587},
url = {https://www.sciencedirect.com/science/article/pii/S1567576926014359?dgcid=rss_sd_all}
}